These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15162542)

  • 1. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China.
    Wang JH; Luo JY; Dong L; Gong J; Tong M
    World J Gastroenterol; 2004 Jun; 10(11):1647-51. PubMed ID: 15162542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China.
    Chen M; Xiong L; Chen H; Xu A; He L; Hu P
    Scand J Gastroenterol; 2005 Jul; 40(7):759-67. PubMed ID: 16118911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China.
    Li YM; Du J; Zhang H; Yu CH
    J Gastroenterol Hepatol; 2008 Feb; 23(2):283-9. PubMed ID: 17645475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
    Fujiwara Y; Kubo M; Kohata Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Intern Med; 2011; 50(21):2443-7. PubMed ID: 22041340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap of gastroesophageal reflux disease and functional bowel disorders in the general Chinese rural population.
    Cai ST; Wang LY; Sun G; Peng LH; Guo X; Wang WF; Yang YS
    J Dig Dis; 2015 Jul; 16(7):395-9. PubMed ID: 25997996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China.
    Ma XQ; Cao Y; Wang R; Yan X; Zhao Y; Zou D; Wallander MA; Johansson S; Liu W; Gu Z; Zhao J; He J
    Dis Esophagus; 2009; 22(4):317-22. PubMed ID: 19207545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with gastroesophageal reflux disease in southern India: A community-based study.
    Chowdhury SD; George G; Ramakrishna K; Ramadass B; Pugazhendhi S; Mechenro J; Jeyaseelan L; Ramakrishna BS
    Indian J Gastroenterol; 2019 Feb; 38(1):77-82. PubMed ID: 30790137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The risk factors and impact of gastroesophageal reflux disease on quality of life in general population].
    Chen HX; Xiong LS; Xu AG; He LJ; Hu PJ; Chen MH
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):202-5. PubMed ID: 16624151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India.
    Wang HY; Leena KB; Plymoth A; Hergens MP; Yin L; Shenoy KT; Ye W
    BMC Gastroenterol; 2016 Mar; 16():36. PubMed ID: 26979399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors of uninvestigated dyspepsia, irritable bowel syndrome, and gastroesophageal reflux disease among students of Damascus University, Syria.
    Al Saadi T; Idris A; Turk T; Alkhatib M
    J Epidemiol Glob Health; 2016 Dec; 6(4):285-293. PubMed ID: 27501053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in northern India.
    Sharma PK; Ahuja V; Madan K; Gupta S; Raizada A; Sharma MP
    Indian J Gastroenterol; 2011 May; 30(3):128-34. PubMed ID: 21061110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.
    Lei WY; Chang WC; Wen SH; Wong MW; Hung JS; Yi CH; Liu TT; Hsu CS; Orr WC; Vaezi MF; Pace F; Hsieh TC; Chen CL
    J Formos Med Assoc; 2019 Apr; 118(4):797-806. PubMed ID: 30584006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.
    do Rosário Dias de Oliveira Latorre M; Medeiros da Silva A; Chinzon D; Eisig JN; Dias-Bastos TR
    World J Gastroenterol; 2014 Dec; 20(46):17388-98. PubMed ID: 25516650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China.
    Wang K; Zhang L; He ZH; Liu ZJ; Zhang L; Hu N; Jin Z; Ke Y; Duan LP
    Chin Med J (Engl); 2019 Jul; 132(13):1516-1523. PubMed ID: 31045906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of gastroesophageal reflux disease in Moscow.
    Bor S; Lazebnik LB; Kitapcioglu G; Manannikof I; Vasiliev Y
    Dis Esophagus; 2016; 29(2):159-65. PubMed ID: 25604401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.